In October 2012, a workshop on research infrastructures (RI) was held in the framework of the FP7-funded TERM project (Tissue Engineering and Regenerative Medicine), whose objective is to encourage and reinforce the attractiveness of European regions by supporting research-driven clusters in that biomedical field. More than 30 representatives within the TERM consortium were invited to demonstrate top-class facilities and share experience on management issues.
According to a recent benchmarking study covering five European regions within the FP7 TERM project, current innovation supports seem to be poorly adapted to bring forth therapies based on these new technologies, due to, at least in part, their high regional fragmentation. Few innovative projects in the field of Tissue Engineering and Regenerative Medicine (TERM) are supported today.
The Scientific Advisory Board (SAB) of the European project TERM, Tissue Engineering and Regenerative Medicine, met recently in London with the consortium, to express its views on the proposals in the vision statement. The SAB confirmed the challenges that the consortium had previously identified, and strongly supports the priorities proposed and shared by all members of the TERM consortium. Once adopted and put in place, they should definitely contribute to a strengthening of Europe’s position in this promising field.
The visit to Berlin-Brandenburg was instrumental to exchange innovative ideas and practices as well as to acquire knowledge and competencies that are needed to build up a Regenerative Medicine cluster in Estonia.
TERM – Estonian study visit to the Berlin-Brandenburg Center for Regenerative Therapies (BCRT) and BioTOP Berlin-Brandenburg (TSB), March 29-30, 2012